0000905148-20-000752.txt : 20200701
0000905148-20-000752.hdr.sgml : 20200701
20200701180851
ACCESSION NUMBER: 0000905148-20-000752
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200701
DATE AS OF CHANGE: 20200701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENNEMAN JOHN B III
CENTRAL INDEX KEY: 0001187572
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 201006364
MAIL ADDRESS:
STREET 1: 311 C ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
form4.xml
X0306
4
2020-06-30
0001781983
Aprea Therapeutics, Inc.
APRE
0001187572
HENNEMAN JOHN B III
535 BOYLSTON STREET
BOSTON
MA
02116
true
Stock Option (right to Buy)
38.78
2020-06-30
4
A
0
5600
0
A
2030-06-30
Common Stock
5600
5600
D
The option vests in full on June 30, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
/s/ Scott M. Coiante, attorney-in-fact
2020-07-01